Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB04928_nanopub.RAp3EbKpXDLrSIXsrD1PBDqVN3_13lWciXr2PBZ7emzRs#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB04928 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04928 label "XP12B [drugbank:DB04928]" assertion.
- drugbank:DB04928 seeAlso DB04928 assertion.
- drugbank:DB04928 description "XP12B is being developed by Xanodyne Pharmaceuticals for the treatment of menorrhagia (heavy menstrual bleeding). It was granted Fast Track status for this indication by the FDA in November 2004." assertion.
- drugbank:DB04928 identifier "drugbank:DB04928" assertion.
- drugbank:DB04928 title "XP12B" assertion.
- drugbank:DB04928 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB04928 drugbank_vocabulary:drugbank-id "DB04928" assertion.
- drugbank:DB04928 bio2rdf_vocabulary:x-identifiers.org DB04928 assertion.
- drugbank:DB04928 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04928" assertion.
- drugbank:DB04928 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04928 bio2rdf_vocabulary:identifier "DB04928" assertion.